JapanPart of Teijinteijin-regenet.com
None yet. When a new project in the record names Teijin Regenet as owner, partner or investor, it shows here.
Joint research will advance manufacturing, automation and quality-control for cell and gene therapies to expand Japan's manufacturing infrastructure and patient access.
